For over three decades, CEI has advocated health care reforms that put more power in the hands of consumers to choose their health providers, treatment protocols, and scope of insurance coverage. We have advocated reform of the Food and Drug Administration’s drug and device approval process to allow for greater flexibility and patient choice. And in 2013, CEI organized the court challenges to Obamacare’s exchange subsidies that concluded with the Supreme Court’s King v. Burwell decision.
Healthcare Issue Areas
Featured Posts
News Release
FDA commissioner resignation opens opportunity for refocus on science over politics
After a somewhat tumultuous tenure, FDA commissioner Marty Makary is stepping down. While Dr. Makary made his mission to accelerate drug approval and bring a…
Blog
Don’t hinder biosimilar development
In its most recent legislative session, the Florida legislature considered precluding pharmacy benefit managers (PBMs) from holding an investment interest in biosimilar manufacturing. That…
Blog
The unseen costs of banning PBM-owned pharmacies in Tennessee
Tennessee lawmakers recently passed the FAIR Rx Act, which would bar companies from owning pharmacies while also operating a pharmacy benefit manager (PBM) and…
Search Posts
Study
Rethinking the Regulation of Bioengineered Crops
Full Document Available in PDF U.S. State Department conference, Agricultural Biotechnology and Developing Countries, May 21,…
Citation
Trade War Looms as US Launches Challenge Over Transgenic Crops
Op-Eds
Mad-Cow Madness: What We Now Know about Mad-Cow Disease Shows the Folly of Excessive Precaution
When Oprah Winfrey stated on her show in 1996 that she'd never eat another hamburger, she was reacting to the remarks of Humane Society…
Op-Eds
Supporting a Risky Water Policy
As <?xml:namespace prefix = st1 ns = “urn:schemas-microsoft-com:office:smarttags” />U.S. environmentalists push policies to phase out use of chlorine gas at water-treatment plants, humanitarians…
Study
Spam, That Ill O’ The ISP
Full Document Available in PDF Most public attention has been focused on…
Op-Eds
Time for the GM Moratorium to Go
After months of anticipation, the U.S. government is expected to file a formal complaint today with the World Trade Organization against the European Union’s five-year…